ID 原文 译文
49158 See laboratory guidance for details: https://www.who.int/emergencies/diseases/novd-coronavirus-2019/technical- guidance/laboratory-guidance 详见实验室指南：https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory- guidance
49160 A contact is a person who experienced any one of the following exposures during the 2 days before and the 14 days after the onset of symptoms of a probable or confirmed case: 接触者是指在可能病例或确诊病例的症状出现前2天和症状出现后14天内与其有过以下任何一种接触的人：
49161 Face-to-face contact with a probable or confirmed case within 1 meter and for more than 15 minutes; 在1米的范围内与可能病例或确诊病例面对面接触超过15分钟；
49162 Direct physical contact with a probable or confirmed case; 与可能病例或确诊病例的直接身体接触；
49163 Direct care for a patient with probable or confirmed COVID-19 disease without using proper personal protective equipment; OR 在没有使用适当的个人防护装备的情况下对COVID-19疾病的可能或确诊患者进行直接护理2;或
49164 Other situations as indicated by local risk assessments. 当地风险评估所示其它情况。
49165 Note: for confirmed asymptomatic cases, the period of contact is measured as the 2 days before through the 14 days after the date on which the sample was taken which led to confirmation. 注：就确诊的无症状病例而言，接触时间是采集样本从而确诊的日期之前的2天到之后的14天。
49166 Recommendations for laboratory testing 关于实验室检测的建议
49167 Any persons meeting the criteria for testing should be tested for COVID-19 infection using available molecular tests. 应采用可用的分子检测法对任何符合检测标准的人进行COVID-19感染检测。
49168 However, depending on the intensity of the transmission, the number of cases and the laboratory capacity, only a subset of the suspect cases may prioritized for testing. 然而，根据传播的强度、病例的数 量和实验室的能力，只有一部分疑似病例可以优先进行检测。